Results 161 to 170 of about 2,202,442 (302)

Correspondence to Charles Conaway

, 1955
This is a letter from John W. Emeigh, Secretary of the National Rural Letter Carriers' Association, sent to Charles Conaway discussing his bill, totaling fourteen dollars and fifty cents, for services he requested.
Delaware Rural Letter Carriers Association
core   +1 more source

Recent progress in nanotechnology-based drug carriers for resveratrol delivery. [PDF]

Drug Deliv, 2023
Li C, Wang Z, Lei H, Zhang D.
europepmc   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Editorial: Driving extracellular vesicles toward applications in precision medicine

Frontiers in Medicine, 2022
Somchai Chutipongtanate, Somchai Chutipongtanate, Somchai Chutipongtanate, Somchai Chutipongtanate, Kovit Pattanapanyasat, Jarek Meller, Jarek Meller, Jarek Meller, Juana Serrano López   +8 more
doaj   +1 more source

The Status of Extracellular Vesicles as Drug Carriers and Therapeutics. [PDF]

Nat Rev Bioeng
Chaudhari AP, Budayr OM, Bonacquisti EE, Kussatz CC, Bannon MS, Law KJ, Liu Y, Bolton ML, Glassman PM, Huang L, Nguyen J.   +10 more
europepmc   +1 more source

Polymer-lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers. [PDF]

Discov Nano, 2023
Salel S, Iyisan B.
europepmc   +1 more source

Effects of IGFBP4 deficiency on human preadipocyte proliferation and differentiation through the IGF1R/AKT pathway

FEBS Open Bio, EarlyView.
IGFBP4 knockdown (KD) impairs preadipocyte proliferation and is associated with IGF1R protein downregulation and attenuated AKT phosphorylation. The mechanisms by which IGFBP4 KD influences the IGF1R/AKT signaling pathway involve newly synthesized proteins and lysosomal degradation pathways. Created in BioRender.
Yujia Guo, Sandy Richter, Christoph Bach, Wieland Kiess, Anna Kirstein, Diana Le Duc, Antje Garten   +6 more
wiley   +1 more source

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

FEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source

Carbon quantum dots as transcutaneous drug carriers: mechanisms, challenges and prospects. [PDF]

RSC Adv
Venugopal V, Kumar BS, Reddy SG, Thota SM.   +3 more
europepmc   +1 more source